A diagnosis of diabetes can point to several more risks to keep in mind—including diabetic foot ulcers. “Diabetic foot ulcers ...

MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...

MediWound, an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it ...

Understanding the risks, symptoms, and prevention methods for diabetic foot conditions is crucial for those with diabetes.

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

At the time, the family had no real understanding of diabetes or how dangerous it could be. But as the months went on, Janse van Vuuren’s condition worsened. He began falling asleep while driving and ...

A patient with diabetic foot infection (DFI) spends 50 per cent of his annual income on treatment, and every year 20,0000 ...